Open access · Peer reviewed · Scopus journal
Baldness, a new marker for coronary heart disease risk
- *
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Sivagnanam G
Email: drsivagnanam@gmail.com
Copyright: © 2013 The Author(s). This is an open access article.
Published: Jan 1, 2013
- DOI
- Not available yet
Abstract
A meta‑analysis of observational studies comprising a total of 36,690 participants showed that vertex baldness is associated with an increased risk of CHD with the relationship depending on the severity of baldness while frontal baldness is not. Thus, it has been suggested that, vertex baldness might be a marker of CHD and is more closely associated with systemic atherosclerosis
Keywords
Subject
Recommended articles
- New(s): Are these terms new(s)!?
G. Sivagnanam · Journal of Pharmacology and Pharmacotherapeutics
- Antibiotics with a curse of cardiovascular risk
G Sivagnanam · Journal of Pharmacology and Pharmacotherapeutics
- Acetaminophen associated with risk of hearing loss: A safety alert
Sangeeta Bhanwra, Kaza Ahluwalia · Journal of Pharmacology and Pharmacotherapeutics
- Majority general practitioners prescribe “Impure Placebo” drugs
· Journal of Pharmacology and Pharmacotherapeutics
- A new drug belonging to a novel class of drugs for type 2 diabetes
Sivagnanam G · Journal of Pharmacology and Pharmacotherapeutics
- The enema of your enemy is your friend
· Journal of Pharmacology and Pharmacotherapeutics
Readers Also Viewed
Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models
Annisa Fatharani, Ali Alsayegh
Jan 1, 2026
Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review
Mohammad Akbar Hossain
Jan 1, 2026
Knowledge, Attitude, and Practice on Digital Eye Strain Among Healthcare Students at a Private University in Northern Peninsular Malaysia
Lim Chin Hung, Subramani Parasuraman, Sam Aaseer Thamby
Jan 1, 2026